Rare diseases
Investigational molecules
Locations
Back to Germany212 clinical trials in Homburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
GermanyStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
GermanyStudy on the Effectiveness of Ethanol in Treating Hypertension in Patients with Uncontrolled High Blood Pressure
GermanyStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
GermanyStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
GermanyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
GermanyStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
GermanyStudy of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
GermanyGermanyStudy of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer
GermanyStudy on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion
GermanyStudy on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lymphoma and leukemia treatments, including studies evaluating novel therapies for chronic lymphocytic leukemia and various types of B-cell lymphomas.
Multiple trials exploring CAR-T cell therapies and targeted treatment combinations.
Comprehensive studies investigating treatments for various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease.
Evaluating new combination therapies and targeted treatments for improved patient outcomes.
Studies addressing heart failure prevention and treatment, with innovative approaches to reducing cardiovascular risks.
Testing novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
